Tag:
OX1
Latest Headlines
Latest Headlines
ViroPharma snags rare disease drug in potential $127M deal
ViroPharma is banking on an anti-oxidant compound to combat a rare neurological disease. The Exton, PA-based company ( $VPHM ) grabbed a worldwide license to the compound from Intellect Neurosciences
